The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
Fid?s brings core strengths across imaging applications and human biology, supporting work in digestive disease, GI oncology, and select solid tumors
GCCL aims to leverage the partnership to expand strategic relationships with global CROs
Ryght AI tackles these hurdles with its AI Site Twin platform
Clinical trial enrollment has long been a bottleneck in drug development
This collaboration turns kitting into a strategic advantage for sponsors and sites
Subscribe To Our Newsletter & Stay Updated
